Orum Therapeutics Inc banner
O

Orum Therapeutics Inc
KOSDAQ:475830

Watchlist Manager
Orum Therapeutics Inc
KOSDAQ:475830
Watchlist
Price: 117 500 KRW 11.59%
Market Cap: ₩2.5T

Orum Therapeutics Inc
Investor Relations

Orum Therapeutics, Inc. operates as a biotechnology company. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2025-02-14. The firm is principally engaged in the research and development of new biopharmaceuticals for cancer and immune diseases based on its platforms.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Sung-Joo Lee Ph.D.
Founder, CEO & Director
No Bio Available
Mr. Martin Intae Jeong
CFO & Director
No Bio Available
Ms. Kayla Mo
Head of Investor Relations
No Bio Available
Mr. Christopher Martin
Head of Legal
No Bio Available
Ms. Susan Best
Vice President of Global Human Resources
No Bio Available
Mr. James Palacino
Head of Research & Senior VP
No Bio Available
Dr. Olaf Christensen M.D.
Chief Medical Officer
No Bio Available
Mr. Greg Dwyer
Head of Business Development
No Bio Available
Mr. Rakan Jeong
Controller
No Bio Available
Ms. S. H. Choi
Treasurer
No Bio Available

Contacts

Address
DAEJEON
DAEJEON
2F, 281-25, Munji-ro, Yuseong-gu
Contacts
+82427163030
www.orumrx.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett